Updates are available Correction dated 2021-12-29
Click to view Correction: https://doi.org/10.1038/s41598-021-04527-7
-
Authors
Madaghiele, Marta
Demitri, Christian
Surano, Ivo
Silvestri, Alessandra
Vitale, Milena
Panteca, Eliana
Zohar, Yishai
Rescigno, Maria
Sannino, Alessandro
-
Funding
Funding for this research was provided by:
Italian Ministry of Economic Development (F/050174/00/X32)
Regione Puglia (FGBFTG7)
- License Information
-
More Information
Article History
Received: 30 July 2021
Accepted: 19 October 2021
First Online: 1 November 2021
Change Date: 29 December 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-021-04527-7
Competing interests
: C. Demitri, Y. Zohar and A. Sannino are co-inventors on multiple patents describing the CB-SAH technology; E. Panteca and Y. Zohar are employees of Gelesis, a biotechnology company working on the development of orally administered CB-SAHs as novel mechanobiological therapeutics; M. Madaghiele, C. Demitri, I. Surano and A. Sannino collaborate with Gelesis as scientific advisors; M. Vitale, A. Silvestri and M. Rescigno declare no conflict of interest.
